mefloquine has been researched along with wr-142,490 in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Adams, DR; Bebbington, D; Benwell, K; Cliffe, IA; Dawson, CE; Dourish, CT; Fletcher, A; Gaur, S; Giles, PR; Gillespie, RJ; Jordan, AM; Knight, AR; Knutsen, LJ; Lawrence, A; Lerpiniere, J; Misra, A; Porter, RH; Pratt, RM; Shepherd, R; Upton, R; Ward, SE; Weiss, SM; Williamson, DS | 1 |
| Allaire, N; Brickelmaier, M; Frisque, RJ; Gorelik, L; Kartikeyan, R; Lugovskoy, A; Reviriego-Mendoza, MM; Simon, K | 1 |
| Agnamey, P; Azas, N; Cohen, A; Damiani, C; Dassonville-Klimpt, A; Dormoi, J; Guillon, J; Marchivie, M; Mullié, C; Pradines, B; Schneider, J; Sonnet, P; Taudon, N; Tisnerat, C; Totet, A | 1 |
3 other study(ies) available for mefloquine and wr-142,490
| Article | Year |
|---|---|
Antagonists of the human adenosine A2A receptor. Part 1: Discovery and synthesis of thieno[3,2-d]pyrimidine-4-methanone derivatives.
Topics: Adenosine A2 Receptor Antagonists; Antimalarials; Antiparkinson Agents; Humans; Models, Chemical; Parkinsonian Disorders; Pyrimidines; Stereoisomerism; Structure-Activity Relationship | 2008 |
Identification and characterization of mefloquine efficacy against JC virus in vitro.
Topics: Antiviral Agents; Astrocytes; Cell Line, Transformed; Cells, Cultured; Humans; JC Virus; Leukoencephalopathy, Progressive Multifocal; Mefloquine; Microbial Sensitivity Tests; Models, Molecular; Neuroglia; Simian virus 40; Virus Replication | 2009 |
Design, synthesis, and characterization of novel aminoalcohol quinolines with strong in vitro antimalarial activity.
Topics: Amino Alcohols; Animals; Antimalarials; Cell Line; Cricetulus; Dose-Response Relationship, Drug; Drug Design; Ether-A-Go-Go Potassium Channels; Female; Humans; Malaria; Mice; Mice, Inbred BALB C; Microsomes, Liver; Molecular Structure; Parasitic Sensitivity Tests; Plasmodium falciparum; Quinolines; Structure-Activity Relationship | 2022 |